Evidence map›Paper›PMID 41624241›Full record

ArticleResearch and practice in thrombosis and haemostasis2026

Response to: "DOACs for Left Ventricular Thrombus: Persistent Equipoise Despite New Observational and Randomized Data".

Hossam Elbenawi, Kirsten Lipps, Samuel Heller, David A Liedl, Raymond C Shields, Ana I Casanegra, Stanislav Henkin, Thom W Rooke, Paul W Wennberg, Waldemar E Wysokinski and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hossam ElbenawiDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Kirsten LippsDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Samuel HellerSecond Faculty of Medicine, Charles University, Prague, Czech Republic.
David A LiedlGonda Vascular Center, Mayo Clinic, Rochester, Minnesota, USA.
Raymond C ShieldsDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Ana I CasanegraDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Stanislav HenkinDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Thom W RookeDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Paul W WennbergDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Waldemar E WysokinskiDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Robert D McBaneDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Damon E HoughtonDivision of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41624241
PMCPMC12860331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.